The stimulation of the human umbilical vein endothelial cell (HUVEC) with recombinant human monocyte-derived colonystimulating factor (MCSF) increased the gene expression of monocyte chemotactic protein (MCP-1). Northern blot analysis indicated that 50 U/ml of MCSF is the optimal concentration for this effect. The elevation of MCP-1 mRNA started as early as 1 h after stimulation and was maintained for at least 8 h. An increased MCP-1 level in MCSF-treated HUVEC was also demonstrated at the protein level by immunocytochemical staining using a polyclonal MCP-1-specific antibody. HUVEC activated by 50 U/ml of MCSF for 5 h showed a stronger immunofluorescence staining than control cells. Micropipette separation of THP-1 monocytes from HUVEC showed that the activation of both THP-1 and endothelium by MCSF led to an increase in the separation force by more than three times (36.2±6.7 X 104 vs. 9.6±3.6 X 10 -dyn). An increased adhesiveness was also observed after MCSF activation of peripheral blood monocytes and HUVEC (16.7±2.7 X 1O-' vs. 5.2±0.9 X 10-4 dyn). The increased adhesive force in both systems was blocked by the use ofanti-MCP-1 (5.5±0.8 X 104 and 6.8±1.1 X 1o-4 dyn). Similar results were obtained in experiments in which only HUVEC, but not monocytes, were activated by MCSF. This increased adhesion of untreated monocytes to MCSF-activated HUVEC was also blocked by the addition of anti-MCP-1. In contrast, experiments in which only THP-1 or peripheral blood monocytes, but not HUVEC, were treated with MCSF did not show a significant increase of adhesion between these cells. These results indicate that MCSF augments monocyte-endothelium interaction primarily by its action on the endothelial cell and that this function is probably mediated through an increased expression of MCP-1. The MCSF/MCP-1-dependent adhesive mechanism might be operative in the arterial wall in vivo to lead to the trapping of the infiltrated monocyte-macrophage in the subendothelial space Preliminary results ofthis study were presented at
Introduction
The intimal recruitment of peripheral blood monocytes to the lesion-prone areas of the arterial tree is an important early event in atherogenesis. The recruited monocytes undergo a differentiation step to become macrophages and may uptake and degrade plasma-derived LDL to develop into foam cells (1) (2) (3) . The monocyte chemotactic protein (MCP-1)' and monocyte colony-stimulating factor (MCSF) are two important cytokines involved in atherogenesis. MCP-l is a glycoprotein with a molecular mass of 14 kD and is expressed in vascular endothehlum (4-6), vascular smooth muscle cells (7, 8) , monocytes (9-1 1 ), and fibroblasts ( 12) . Its primary function is to serve as a chemoattractant for monocytes (13) . The MCP-1 gene belongs to an early response small gene superfamily (14) (15) (16) . MCSF, also known as CSF-1, is a hematopoietic growth factor stimulating the differentiation and proliferation of monocytic progenitor cells (17, 18) . MCSF is also expressed in vascular cells ( 19, 20) and is a glycosylated homodimer with a molecular mass of45 kD (21) .
Minimally modified LDL (MM-LDL) has been shown to activate the expression of both MCP-1 and MCSF in cultured endothelial cells and in mice models in vivo (22) (23) (24) . Transmigration of monocytes into the subendothelial space induced by LDL was inhibited by antibody to . MCSF has been shown to enhance the clearance of LDL in experimental animals (26, 27) , and the uptake and degradation ofacetylated LDL in cultured macrophages (28) . Both MCP-1 and MCSF have been located in atherosclerotic lesions of humans and rabbit models ( 19, 29, 30) . Although these two cytokines have been implicated in atherogenesis by many investigators, little direct evidence is available concerning the roles they play in the accumulation of monocyte-macrophages in the arterial wall.
In the present study, we provide evidence that recombinant human MCSF activates MCP-1 gene expression in the human umbilical vein endothelial cell (HUVEC). In addition, using a micropipette aspiration technique, we have found that MCSF acts on the endothelium to increase the adhesive force between monocytes and HUVEC, and that this MCSF-induced adhesion is blockedhbyan antibody specific to MCP-1. These find- 
Methods
Cell cultures. HUVEC were isolated from the human umbilical cord as described by Jaffe et al. (31 ) . The cells were grown in M-199 media containing 15% FCS supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 Ag/ml streptomycin, and 1 mM sodium pyruvate. All the cells used were before passage seven. Human peripheral blood monocytes were isolated from freshly drawn blood by first mixing 10 parts of the blood with 1 part of 0.9% NaCl (wt/vol) containing 6% dextran 500. After the erythrocytes had settled, the leukocyte-rich plasma was layered on NycoPrep 1.068 (Accurate Chemical Co., Westbury, NY) followed by centrifugation at 600 g for 15 min. The NycoPrep 1.068 layer was suspended with 0.9% NaCl containing 0.13% (wt/ vol) EDTA and 1% FCS. The cell suspension was further centrifuged at 600 g for 7 min. Platelets were finally removed by suspending the cell pellet in Hank's buffer and layering the cell suspension on NycoPrep 1.063 for centrifugation at 350 g for 5 min. The monocyte pellet was then suspended in RPMI 1640 supplemented with 10% FCS, 2 mM L-glutamine, 100 U/ml penicillin, 100 Ag/ml streptomycin, and 100 MM f3-mercaptoethanol. The isolated cells were used within 12 h after isolation. The human monocytic cell line THP-1 was obtained from the American Type Culture Collection (Rockville, MD) and maintained in RPMI as described above. All cell cultures were maintained in a humidified 5% C02, 95% air incubator at 37°C.
RNA isolation and Northern blot analysis. HUVEC grown to confluency were washed twice with PBS and stimulated with recombinant human MCSF (Genzyme, Boston, MA). Total cellular RNA was isolated by using the guanidinium isothiocyanate/CsCl method as previously described (32) . In brief, the monolayer was washed and lysed with 4 M guanidium isothiocyanate. The cell extract was layered on a cushion of 5.7 M CsCl and ultracentrifuged at 42,000 rpm for 20 h. The RNA sediment on the bottom ofthe ultracentrifuge tube was recovered and purified by ethanol precipitation. 20 Mg of the isolated RNA from each sample was loaded on a 1.5% formaldehyde agarose gel and subjected to electrophoresis. RNA was transferred to a nylon membrane for hybridization at 42°C for 18 h with either a 32P-labeled oligonucleotide 48mer complimentary to the coding sequence ofhuman MCP-I or 32P-labeled 0.6-kb baboon vascular smooth muscle cell MCP-I cDNA. The hybridization buffer contained 50% (vol/vol) formamide, 5X SSC, 0.5x Denhardt's solution, 0.1% (vol/vol) SDS, and 100 ,g/ml salmon sperm DNA. The membrane was then washed and exposed to Kodak X-Omat XAR film at -70°C.
Immunocytochemistry andfluorescence microscopy. The HUVEC cultures on coverslips contained in six-well culture plates were grown to confluency and stimulated with MCSF (50 U/ ml). After incubation at 37°C for 5 h, the HUVEC monolayers were washed with warm PBS and fixed with 1% (vol/vol) formalin in PBS for 10 min. The first antibody, anti-MCP-l, is a polyclonal antibody raised in the rabbit against a baboon MCP-1 (8, 33) . Anti-MCP-l, 2% (vol/vol) in PBS containing 2% albumin, was applied to the fixed HUVEC and incubated at 37°C for 1 h, followed by three 5-min washes with PBS. The second antibody, tetramethylrhodamine isothiocyanate (TRITC)-conjugated goat anti-rabbit IgG (Sigma Chemical Co., St. Louis, MO) with a dilution of 1 :100, was then introduced for a second incubation at 37°C for 1 h. After three PBS washes, the coverslips were inverted and mounted on microscopic slides. An epi-fluorescence microscope (Microphot-FX; Nikon) equipped with a diascopic phase-contrast attachment was used to study the fluorescence intensity in the HUVEC monolayer. The observation was made with an excitation filter at 450-490 nm, a dichroic mirror at 510 nm, and a barrier filter at 520 nm.
Micropipette assay of the adheringforce of monocytes to the HU-VEC monolayer. The assay was performed on both the THP-I monocytic cell line and freshly isolated peripheral blood monocytes. In coactivation experiments in which both monocytes and HUVEC were exposed to MCSF, the confluent HUVEC monolayer cultured in plastic chambers (r = 0.5 cm) was first washed twice with warm culture medium, then incubated for 30 min with or without anti-MCP-l (1% [vol/vol]), and followed by the addition ofMCSF (50 U/ml). Monocytes ( -04' cells) were washed twice with warm M-199 medium and added into the HUVEC chamber for 3 h of coincubation before the micropipette aspiration assay. In experiments in which only the HU-VEC were activated, the monolayer was first treated with MCSF, or MCSF plus anti-MCP-1, for 3 h. The activated monolayer was washed twice with warm M-199 medium and incubated with untreated monocytes for 1 h before the micropipette aspiration assay. In experiments in which only the monocytes were activated, THP-l cells or peripheral blood monocytes were first incubated in M-199 media supplemented with MCSF, or MCSF plus anti-MCP-l, for 3 h. The cells were washed twice and then added to the unstimulated HUVEC monolayer for 1 h of incubation before the aspiration assay.
The procedure of the micropipette aspiration has been described previously (34, 35) . In brief, micropipettes with an internal radius (Rp) of 1.6-3.3 ,m were manipulated by using a hydraulic micromanipulator (Narishige Scientific Instrument Lab., Tokyo, Japan) mounted on the stage of an inverted microscope. The tip of the pipette was positioned in the cell chamber, and the wide end was connected to a pressure regulation system. Monocytes adhering to the HUVEC monolayer were randomly chosen and held at the tip ofthe pipette by the application of an initial aspiration pressure. When the force due to the aspiration pressure was insufficient to balance the adhesive force, the THP-1 would slip out of the micropipette when the latter was pulled away by micromanipulation. The MCSF increases the adhesive force between THP-J and HUVEC, and this effect is blocked by anti-MCP-J. We tested whether the treatment of HUVEC and monocytes by MCSF (coactivation experiments) increased their adhesion by measuring the critical separation force in micropipette aspiration tests. Separation forces were calculated and subjected to statistical analysis. In a few cases, monocytes could not be separated from the HUVEC even with a aspiration pressure as high as 1,000 mmH2O; this magnitude of aspiration pressure was used to calculate the separation force for these nonseparable cells. As shown in Fig. 4 , while a Fc of 36.2+6.7 X 10-4 dyn was needed to separate the THP-1 from HUVEC in these coactivation experiments, a value of 9.6±3.6 X 10-4 dyn was found in control experiments. The addition ofanti-MCP-1 blocked the increase in cellular adhesion caused by MCSF and reduced the separation force to 5.5±0.8 x 10-4 dyn. As indicated in Table I , similar results were also obtained in experiments in which peripheral blood monocytes were aspirated from HUVEC mono- The control experiments in HUVEC activation and monocytes activation were the same. ' F, values were not statistically different from those for control and (MCSF + anti-MCP-l ) groups.
adhesion of monocytes, i.e., THP-l or peripheral blood monocytes, to HUVEC monolayers is enhanced by MCSF, and this effect is blocked by an antibody specific to MCP-1. Third, such augmentation of cellular interaction by MCSF is primarily through its action on the endothelial cell rather than the monocyte.
Cushing et al. and Rajavashisth et al. (22, 23) observed increased levels of MCSF and MCP-l transcripts in vascular endothelium treated with MM-LDL. Our finding ofthe upregulation of MCP-1 transcripts in HUVEC by an optimal concentration of MCSF (Fig. 1) suggests that the signal transduction pathway leading to the MCP-1 gene expression in response to MM-LDL may be partially mediated via MCSF. In addition to MM-LDL, the stimulation of gene expressions of MCSF and MCP-l in cultured vascular endothelium by common stimuli has been reported in many other conditions, including plateletderived growth factor (PDGF) (9, 36, 37) , bacterial LPS (6, 19) , recombinant human tumor necrosis factor-a (TNF-a) (4, 6, 19), and recombinant human IL-1 (4, 6, 19, 38) . In accordance with the present findings, the induced MCSF in the endothelial cells activated by these stimuli would further increase the gene expression of MCP-1. An optimal stimuli concentration to induce the expression ofMCP-1 is not unique to MCSF. For example, l0-7 M of 12-0-tetradecanoyl-phorbol-13-acetate (TPA) and 100 ng/ml of LPS have been shown to be the optimal concentrations required to induce the maximum levels of MCP-I transcripts in HUVEC or fibroblasts (32, 39) . In a separate time course experiment, we found that the level of MCP-1 transcripts in cells treated with MCSF for 16 h was similar to those treated for 4 h. This together with the data shown in Fig. 2 indicate that the induced increase in the levels of MCP-1 message sustained for at least 8 h. Thus, the signal transduction pathway in MCSF-induced MCP-1 gene activation may differ at least partly from that in the transient expression of MCP-l in TPA-stimulated HUVEC (32) or in LPSstimulated BALB/c 3T3 cells (39) .
Micropipette aspiration has been used widely in investigations on cellular interactions (34, 35) . In the present study, this technique was used to assess the adhesive force between monocytes and MCSF-activated HUVEC. We also performed the conventional attachment assays (40) , and the preliminary results are consistent with the findings in the present micropipette tests. The micropipette aspiration technique has the important advantage of assessing the adhesive force of each attached monocyte individually and quantitatively, information that can not be obtained in the attachment assay. The coactivation ofeither THP-1 or freshly isolated peripheral blood monocytes and HUVEC with MCSF caused more than threefold increases in the critical separation force when compared with that in controls, and this increased adhesion was effectively blocked by anti-MCP-1 (Fig. 4) . These data suggest that MCP-1 may act not only as a chemoattractant molecule ( 10, 13) , but also as a factor for increasing the strength of monocyte-endothelium interaction. It is possible that the induction pathway for MCSF/MCP-1 expression interacts with the regulatory pathway for the expression of adhesion molecules such as the endothelium-leukocyte adhesion molecule (ELAM-1), intercellular adhesion molecule (ICAM-1), and vascular cell adhesion molecule (VCAM-I ) on the surface ofthe endothelial cell. Although there are no previous reports that MCSF leads to the expression of adhesion molecules on endothelium, the above hypothesis is supported indirectly by the observations in vivo that VCAM-I and ICAM-1 are expressed in the atherosclerotic lesions in which MCSF/MCP-1 expression are known to be active (41, 42) . In addition, the stimuli that cause an increase in the gene expression ofboth MCSF and MCP-1 have all been shown to increase the adhesion of monocytes to endothelial cells (43) , and this may be due to the upregulation ofadhesion molecules (44) (45) (46) (47) 
